(Q28480907)

English

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome (English)

0 references

multiple sclerosis

0 references

clinically isolated syndrome

1 reference

based on heuristic

inferred from title

Edgardo Cristiano

object named as

Edgardo Cristiano

18

0 references

Vilija Jokubaitis

object named as

Vilija G Jokubaitis

3

0 references

Carolyn A. Young

object named as

Carolyn Young

29

0 references

object named as

Mark Slee

25

0 references

Helmut Butzkueven

object named as

Helmut Butzkueven

33

0 references

Alessandra Lugaresi

object named as

Alessandra Lugaresi

9

0 references

object named as

Maria Trojano

4

0 references

object named as

Eva Havrdova

28

0 references

Roberto Bergamaschi

21

object named as

Roberto Bergamaschi

0 references

Guillermo Izquierdo

5

object named as

Guillermo Izquierdo

0 references

Pierre Grammond

11

object named as

Pierre Grammond

0 references

Michael Barnett

27

object named as

Michael Barnett

0 references

author name string

Claire Meyniel

1

0 references

Timothy Spelman

2

0 references

François Grand'Maison

6

0 references

Celia Oreja-Guevara

7

0 references

Cavit Boz

8

0 references

Marc Girard

10

0 references

Gerardo Iuliano

12

0 references

Marcela Fiol

13

0 references

Jose Antonio Cabrera-Gomez

14

0 references

Ricardo Fernandez-Bolanos

15

0 references

Giorgio Giuliani

16

0 references

Jeannette Lechner-Scott

17

0 references

Joseph Herbert

19

0 references

Tatjana Petkovska-Boskova

20

0 references

Vincent van Pesch

22

0 references

Fraser Moore

23

0 references

Norbert Vella

24

0 references

Vetere Santiago

26

0 references

Carmen-Adella Sirbu

30

0 references

Mary Tanner

31

0 references

Michelle Rutherford

32

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

6

0 references

e38661

0 references

copyright license

Creative Commons Attribution 4.0 International

29 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

19 March 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

19 March 2017

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

19 March 2017

Registry studies of long-term multiple sclerosis outcomes: description of key registries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Medication adherence with disease modifying treatments for multiple sclerosis among US employees

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

EDMUS, a European database for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

29 September 2017

Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

2 June 2018

A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

2 June 2018

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038661

21 January 2018

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038661

21 January 2018

Persistence and adherence to disease modifying drugs among patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038661

21 January 2018

Long-term interferon-beta treatment for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038661

21 January 2018

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038661

21 January 2018

Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038661

21 January 2018

Participation in medical decision-making: attitudes of Italians with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

27 November 2018

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387159

27 November 2018

Tolerability, adherence, and patient outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22768046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta-1b treatment in patients with relapsing--remitting multiple sclerosis under a standardized protocol in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/22768046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain atrophy, interferon beta, and treatment trials in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22768046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event

1 reference

https://pubmed.ncbi.nlm.nih.gov/22768046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0038661

0 references

2012PLoSO...738661M

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28480907&oldid=1867062098"